Semperit AG Holding: Semperit owns more than 95% of Latexx Partners – Delisting from Bursa Malaysia

The publicly listed Semperit Group has increased its shareholding in the Malaysian company Latexx Partners Berhad to more than 95% on a diluted basis within the context of the delisting from Bursa Malaysia (the stock exchange of Malaysia) and the related “exit offer” for all outstanding shares and warrants. The delisting of Latexx Partners can now be carried out as intended following the closing of the “exit offer”.

As a result of the delisting, trading of Latexx Partners’ shares has been suspended since May 23, 2013 and its’ listing on Bursa Malaysia will cease on June 5, 2013. Currently the remaining shareholders of Latexx Partners have a further three months to sell their shares and warrants to Semperit Group under the same conditions as in the “exit offer“.

A further step in the acquisition of Latexx Partners was successfully taken on the basis of the delisting. The integration of the Malaysian glove producer in the Medical Sector of the Semperit Group is on schedule and has already generated benefits in the first quarter of 2013. The improved global presence, expanded customer base and capacity increases resulting from the acquisition of Latexx Partners will have a positive effect on Semperit Group’s business development for the rest of the year.

About Semperit
The publicly listed Semperit AG Holding is an internationally-oriented group that develops, produces, and sells highly specialised rubber and plastic products for the medical and industrial sectors: examination and surgical gloves, hydraulic and industrial hoses, conveyor belts, escalator handrails, construction profiles, cable car rings, and products for railway superstructures. The headquarters of this long-standing Austrian company, which was founded in 1824, are located in Vienna, and the global R & D centre is in Wimpassing, Lower Austria. The Semperit Group employs more than 10,000 people worldwide, including more than 7,000 in Asia and more than 700 in Austria. The group has 22 manufacturing facilities worldwide and numerous sales offices in Europe, Asia, and America. In fiscal 2012, the group generated revenue of EUR 829 million and an EBITDA of EUR 109 million.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)